Market News

Insmed (INSM) Holder University Of Notre Dame Du Lac Decreased Position; Clearline Capital LP Raised Position in Resh Hldgs (INCR) by $7.00 Million

SYNEOS HEALTH INC COM USD0.01 C (NASDAQ:INCR) Logo

Marc Majzner increased its stake in Inc Resh Hldgs Inc (INCR) by 100.13% based on its latest 2017Q4 regulatory filing with the SEC. Clearline Capital Lp bought 162,722 shares as the company’s stock 0.00% . The hedge fund run by Marc Majzner held 325,230 shares of the health care company at the end of 2017Q4, valued at $14.18M, up from 162,508 at the end of the previous reported quarter. Clearline Capital Lp who had been investing in Inc Resh Hldgs Inc for a number of months, seems to be bullish on the $ market cap company. The stock decreased 1.94% or $0.8 during the last trading session, reaching $40.5. About 1.48 million shares traded or Infinity% up from the average. SYNEOS HEALTH INC COM USD0.01 C (NASDAQ:INCR) has 0.00% since May 13, 2017 and is . It has underperformed by 11.55% the S&P500.

University Of Notre Dame Du Lac decreased its stake in Insmed Inc (INSM) by 56.96% based on its latest 2017Q4 regulatory filing with the SEC. University Of Notre Dame Du Lac sold 115,292 shares as the company’s stock declined 30.16% with the market. The institutional investor held 87,121 shares of the health care company at the end of 2017Q4, valued at $2.72M, down from 202,413 at the end of the previous reported quarter. University Of Notre Dame Du Lac who had been investing in Insmed Inc for a number of months, seems to be less bullish one the $2.09B market cap company. The stock increased 2.40% or $0.64 during the last trading session, reaching $27.33. About 304,734 shares traded. Insmed Incorporated (NASDAQ:INSM) has risen 31.10% since May 13, 2017 and is uptrending. It has outperformed by 19.55% the S&P500.

More notable recent Insmed Incorporated (NASDAQ:INSM) news were published by: Nasdaq.com which released: “Insmed Reports First Quarter 2018 Financial Results and Provides Business Update” on May 02, 2018, also Benzinga.com with their article: “Insmed Shares To Outperform Through 2018 After ‘Slow Start,’ Credit Suisse Says In Upgrade” published on April 23, 2018, Nasdaq.com published: “Mid-Morning Market Update: Markets Mostly Flat; Hasbro Misses Q1 Expectations” on April 23, 2018. More interesting news about Insmed Incorporated (NASDAQ:INSM) were released by: Benzinga.com and their article: “The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap” published on April 29, 2018 as well as Streetinsider.com‘s news article titled: “Insmed (INSM) PT Raised to $56 at Cowen” with publication date: May 02, 2018.

University Of Notre Dame Du Lac, which manages about $481.90M US Long portfolio, upped its stake in Herbalife Ltd (NYSE:HLF) by 33,714 shares to 109,930 shares, valued at $7.44 million in 2017Q4, according to the filing. It also increased its holding in Alphabet Inc by 10,590 shares in the quarter, for a total of 20,902 shares, and has risen its stake in Ptc Inc (NASDAQ:PTC).

Among 12 analysts covering Insmed (NASDAQ:INSM), 10 have Buy rating, 0 Sell and 2 Hold. Therefore 83% are positive. Insmed had 28 analyst reports since August 10, 2015 according to SRatingsIntel. The company was upgraded on Thursday, January 4 by Stifel Nicolaus. Cowen & Co maintained Insmed Incorporated (NASDAQ:INSM) on Thursday, August 3 with “Buy” rating. As per Thursday, July 20, the company rating was maintained by H.C. Wainwright. Stifel Nicolaus maintained Insmed Incorporated (NASDAQ:INSM) rating on Thursday, November 2. Stifel Nicolaus has “Buy” rating and $43.0 target. H.C. Wainwright maintained Insmed Incorporated (NASDAQ:INSM) on Tuesday, October 6 with “Buy” rating. The stock has “Hold” rating by Zacks on Monday, August 10. The rating was maintained by Cowen & Co with “Buy” on Monday, September 11. The company was upgraded on Thursday, August 20 by Zacks. The firm earned “Buy” rating on Tuesday, March 15 by Stifel Nicolaus. The firm earned “Buy” rating on Monday, October 30 by Robert W. Baird.

Investors sentiment decreased to 1 in 2017 Q4. Its down 2.74, from 3.74 in 2017Q3. It fall, as 27 investors sold INSM shares while 40 reduced holdings. 18 funds opened positions while 49 raised stakes. 73.21 million shares or 49.25% less from 144.25 million shares in 2017Q3 were reported. Prudential Fincl stated it has 0% in Insmed Incorporated (NASDAQ:INSM). Moreover, Proshare Advisors Ltd Liability Co has 0.01% invested in Insmed Incorporated (NASDAQ:INSM) for 52,620 shares. Blackrock stated it has 7.83M shares. Natl Bank Of Ny Mellon accumulated 420,220 shares or 0% of the stock. Gsa Cap Limited Liability Partnership owns 19,824 shares or 0.04% of their US portfolio. Goldman Sachs Gp reported 0% in Insmed Incorporated (NASDAQ:INSM). Principal Fincl Grp owns 0% invested in Insmed Incorporated (NASDAQ:INSM) for 156,420 shares. Hbk LP owns 46,275 shares or 0.01% of their US portfolio. Bp Public reported 0.01% in Insmed Incorporated (NASDAQ:INSM). Millennium Ltd Liability Company, a New York-based fund reported 23,389 shares. 207,190 were accumulated by Jpmorgan Chase. Omega Advsrs Inc owns 155,000 shares or 0.18% of their US portfolio. Vanguard invested 0.01% of its portfolio in Insmed Incorporated (NASDAQ:INSM). Wells Fargo Mn owns 43,763 shares or 0% of their US portfolio. State Of Wisconsin Investment Board holds 0.01% in Insmed Incorporated (NASDAQ:INSM) or 74,200 shares.

Investors sentiment decreased to 0.68 in Q4 2017. Its down 0.89, from 1.57 in 2017Q3. It turned negative, as 73 investors sold INCR shares while 53 reduced holdings. 27 funds opened positions while 59 raised stakes. 78.16 million shares or 23.75% less from 102.50 million shares in 2017Q3 were reported. Cooke & Bieler Lp, Pennsylvania-based fund reported 1.30 million shares. Citadel Advsrs, Illinois-based fund reported 251,357 shares. Highline Capital Mgmt LP owns 626,400 shares. Us Bank & Trust De owns 333 shares or 0% of their US portfolio. Jana Ptnrs Ltd Liability Co reported 1.52% in SYNEOS HEALTH INC COM USD0.01 C (NASDAQ:INCR). Price T Rowe Associates Md has 548,249 shares. Iowa-based At Bancorporation has invested 0.04% in SYNEOS HEALTH INC COM USD0.01 C (NASDAQ:INCR). Acadian Asset Limited Liability holds 0% of its portfolio in SYNEOS HEALTH INC COM USD0.01 C (NASDAQ:INCR) for 8,955 shares. Narwhal Cap Mngmt invested in 11,690 shares or 0.12% of the stock. Ls Inv Advsrs Ltd Liability has invested 0.01% in SYNEOS HEALTH INC COM USD0.01 C (NASDAQ:INCR). The Connecticut-based Cubist Systematic Strategies Ltd Liability Company has invested 0.14% in SYNEOS HEALTH INC COM USD0.01 C (NASDAQ:INCR). Ubs Asset Mngmt Americas Incorporated accumulated 0% or 27,299 shares. Federated Investors Pa invested in 14,506 shares. Clearbridge Lc stated it has 290,068 shares. Buffington Mohr Mcneal, Idaho-based fund reported 68,560 shares.

Among 13 analysts covering INC Research Holdings (NASDAQ:INCR), 8 have Buy rating, 0 Sell and 5 Hold. Therefore 62% are positive. INC Research Holdings had 36 analyst reports since August 14, 2015 according to SRatingsIntel. The rating was upgraded by SunTrust to “Buy” on Wednesday, May 31. Robert W. Baird maintained SYNEOS HEALTH INC COM USD0.01 C (NASDAQ:INCR) on Monday, October 9 with “Buy” rating. Credit Suisse maintained SYNEOS HEALTH INC COM USD0.01 C (NASDAQ:INCR) on Tuesday, November 14 with “Buy” rating. The rating was maintained by Jefferies with “Hold” on Monday, September 11. The rating was upgraded by Robert W. Baird on Thursday, May 11 to “Outperform”. The stock has “Overweight” rating by JP Morgan on Thursday, March 24. The firm has “Buy” rating given on Monday, November 13 by KeyBanc Capital Markets. Credit Suisse maintained the shares of INCR in report on Wednesday, October 11 with “Outperform” rating. The rating was maintained by Mizuho on Friday, December 1 with “Hold”. As per Friday, August 12, the company rating was maintained by Goldman Sachs.

Insmed Incorporated (NASDAQ:INSM) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *